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Abstract 27 
Background/Objectives: Obesity can affect muscle phenotypes, and may thereby constrain 28 
movement and energy expenditure. Weight loss is a common and intuitive intervention for 29 
obesity, but it is not known whether the effects of obesity on muscle function are reversible 30 
by weight loss. Here we tested whether obesity-induced changes in muscle metabolic and 31 
contractile phenotypes are reversible by weight loss.  32 
Subjects/Methods: We used zebrafish (Danio rerio) in a factorial design to compare energy 33 
metabolism, locomotor capacity, muscle isometric force and work-loop power output, and 34 
myosin heavy chain composition between lean fish, diet-induced obese fish, and fish that 35 
were obese and then returned to lean body mass following diet restriction. 36 
Results: Obesity increased resting metabolic rates (p < 0.001) and decreased maximal 37 
metabolic rates (p = 0.030), but these changes were reversible by weight- loss, and were not 38 
associated with changes in muscle citrate synthase activity. In contrast, obesity-induced 39 
decreases in locomotor performance (p = 0.0034), and isolated muscle isometric stress (p = 40 
0.01), work loop power output (p < 0.001), and relaxation rates (p = 0.012) were not reversed 41 
by weight loss. Similarly, obesity-induced decreases in concentrations of fast and slow 42 
myosin heavy chains, and a shift towards fast myosin heavy chains were not reversed by 43 
weight loss.   44 
Conclusion: Obesity-induced changes in locomotor performance and muscle contractile 45 
function were not reversible by weight loss. These results show that weight loss alone may 46 
not be a sufficient intervention. 47 
 48 
 49 
 50 
 51 
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Introduction 52 
 Skeletal muscle is essential for locomotion and posture 1, as well as for whole-body 53 
energy homeostasis and metabolism 2,3. Hence, any impairment of muscle function will 54 
impact on the health and fitness of the whole organism. Obesity has detrimental effects on 55 
metabolic phenotypes and muscle function 4. The consequences of these effects will be 56 
compounded if they persist in individuals that have undergone successful weight-loss 57 
therapy. It is therefore essential to determine the reversibility of obesity-induced 58 
physiological changes in order to predict the potential consequences of obesity and the 59 
efficacy of treatments. Our aim was to determine whether diet-induced obesity impairs 60 
locomotor capacity and muscle function, and whether any effects are reversible with weight 61 
loss. Skeletal muscle function is dependent on the contractile and calcium signaling proteins 62 
that mediate contraction and relaxation, and on energy metabolism to supply the necessary 63 
ATP 5. We therefore investigated metabolism in parallel with muscle contractile function. 64 
 Many signalling pathways associated with energy homeostasis are conserved among 65 
vertebrates and are similar in a number of model species, including humans, rodents, and 66 
zebrafish 6,7. One of the principal mediators of obesity-induced metabolic dysfunction is a 67 
reduction in concentration and activity of the sirtuin SIRT14,8. SIRT1 is a NAD+-dependent 68 
histone deacetylase that promotes expression of a range of metabolic regulators such as PGC-69 
1alpha 9, and thereby regulates mitochondrial function 10. Mice lacking SIRT1 had reduced 70 
activity and reduced rates of oxygen consumption, leading to an overall decrease in energy 71 
expenditure 11. Conversely, increased expression of SIRT1 led to increased energy 72 
expenditure12. Obesity-induced mitochondrial dysfunction in skeletal muscle manifests as 73 
decreased TCA cycle (citrate synthase) activity and electron transport chain flux 13. It would 74 
be expected therefore that this reduction in maximal metabolic capacities would lead to a 75 
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reduction in metabolic scope, which represents the energy available for activity and 76 
locomotion.  77 
 Locomotor performance is determined by dynamic muscular contractility rather than 78 
by isometric force production, and the capacity of muscles to produce work during the 79 
shortening and lengthening cycle, and the passive resistance to stretch determine muscle 80 
power output (work-loop performance) 14,15. When normalized to muscle mass, work-loop 81 
power output of isolated skeletal muscle was reduced in faster muscle fibre types of obese 82 
mice 16. A possible cause for changes in muscle power output are obesity-induced shifts in 83 
the expression of slow (oxidative) type I myosin heavy chains 17-19, although fibre type shifts  84 
can differ between males and females 19. Obesity also altered locomotor capacity 20 and the 85 
metabolic cost of locomotion 21, which could be associated with changes in muscle 86 
contractile properties. Although obesity is well known to constrain physical performance22,23, 87 
beyond a single mouse study 24 the effect of obesity on muscle power output are unknown, 88 
and it remains to be shown whether there is a link between muscle power output and 89 
locomotion, and whether any obesity-induced changes are reversible with weight loss.  90 
 Weight loss reversed obesity-induced increases in pro-inflammatory proteins 25, 91 
reductions in adiponectin levels26, impaired lymphatic function 27, metabolic dysfunction 92 
28,29, and reduction in slow type I myosin heavy chains 17. However, at least with respect to 93 
kidney function it is not clear whether the effects of obesity are reversible by weight loss 30. 94 
Overall, it may be expected that obesity-induced declines in physiological function are 95 
reversed by weight loss. However, the physiological effects of obesity are so complex that it 96 
is difficult to extrapolate between physiological systems. Hence, we tested whether obesity-97 
induced impacts on muscle and locomotor function are reversible by weight loss.  98 
 We used zebrafish to test the hypotheses that a) obesity reduces metabolic scope and 99 
muscle citrate synthase activity because of mitochondrial dysfunction; b) obesity reduces 100 
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isolated muscle power output; we predicted that these changes in contractile function are 101 
associated with decreases in whole-animal locomotor performance, and changes in myosin 102 
heavy chain composition; c) obesity-induced changes in metabolism, skeletal muscle and 103 
locomotor phenotypes are reversible by weight loss.  104 
 105 
Materials and Methods 106 
Study animals and treatments 107 
 All procedures were performed with the approval of the University of Sydney Animal 108 
Ethics Committee (approval #723). Adult zebrafish (Danio rerio) were obtained from a 109 
commercial supplier (Livefish, Bundaberg, Australia) and maintained in plastic tanks (600 x 110 
450 x 250 mm; 1-2 fish l-1) with dechlorinated water at 25oC, and a 12h dark:12 h light 111 
photoperiod for two weeks before experimentation, and fed with commercial fish flakes 112 
(Wardley's, The Hartz Mountain Company, Secaucus, USA; 46% protein, 6% fat). After two 113 
weeks fish were randomly allocated to one of three groups: 1) control fish were fed once a 114 
day to satiety for 9-10 weeks; 2) obese fish fed three times per day to satiety for 9-10 weeks; 115 
3) obese-lean fish were fed three times per day for 4-5 weeks, then once per day for 4-5 116 
weeks. We took photos of each fish (with an Exilim camera, Casio, Japan) to determine 117 
standard length (in ImageJ software, NIH, USA), and we weighed fish before treatments, 118 
again at the time when obese-lean fish were switched to the lean diet, and at the end of the 119 
treatments immediately before measurements were taken.  120 
 121 
Metabolism and swimming performance 122 
Metabolic scope, that is the difference between resting and maximal metabolic rates, 123 
represents the energy (ATP) available for activity 31. Resting metabolic rate represents the 124 
energetic costs to maintain membrane potential, protein synthesis and other processes 125 
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occurring while the animal is at rest. Maximal metabolic rate reflects the maximal 126 
mitochondrial and cardiovascular capacities 31. We measured (n = 12 lean fish, 14 obese, and 127 
9 obese-lean fish for all measures of oxygen consumption) resting and maximal oxygen 128 
consumption rates according to our previously published protocols 32,33 at 25oC. 129 
 Citrate synthase (CS) is a rate limiting enzyme in the TCA cycle, and its activity 130 
reflects mitochondrial densities in tissue samples 34. Fish (n = 8 fish per treatment group) 131 
were anaesthetised in buffered ethyl 3-aminobenzoate methanesulfonate (MS222; 0.3 g l-1; 132 
Sigma-Aldrich, Castle Hill, Australia) and euthanized by decapitation. Dorsal (back) and 133 
caudal (tail) skeletal muscle was extracted and immediately transferred to liquid nitrogen and 134 
stored at -80°C. Muscle samples were homogenised (in a TissueLyser LT; Qiagen, Venlo, 135 
Netherlands) in 9 volumes RIPA buffer (20mM TrisCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 136 
1 mM EGTA, 1% NP40, 1% sodium deoxycholate) and protease inhibitor cocktail 137 
(cӨmplete, EDTA-free; Roche Life Sciences, Germany) solution. Homogenate was further 138 
diluted by a factor of 10 to a final 1:100 dilution. Following published protocols 35, enzyme 139 
activities were determined using a UV/visible spectrophotometer (Ultrospec 2100 Pro; 140 
Biochrom, UK) with a temperature controlled cuvette holder. Assays were performed in 141 
duplicate at 25°C.  142 
 Sustained swimming performance was measured (in n = 12 lean, 14 obese, and 9 143 
obese-lean fish) as critical sustained swimming speed (Ucrit) 36 in a Blazka-type swimming 144 
flume according to published protocols 32. The Ucrit protocol uses an incremental increase in 145 
speed (Ui) for predetermined time intervals (Ti) until fish are fatigued as a measure of 146 
maximum locomotor capacity 36.  147 
 148 
 Muscle biomechanics 149 
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 Fish (n = 10 per treatment group) were euthanized via a blow to the head, and 150 
transection of the spinal cord.  The skin was removed and a section of rostral (anterior dorsal) 151 
muscle fibres of 5 to 7 myotomes in length was dissected from one side of the fish in cooled 152 
(<5C) aerated fish Ringer’s solution (composition in mmol l-1: NaCl 115.7; sodium pyruvate 153 
8.4; KCl 2.7; MgCl2 1.2; NaHCO3 5.6; NaH2PO4 0.64; HEPES sodium salt 3.2; HEPES 0.97; 154 
CaCl2 2.1; pH 7.4 at 20C) 37. The spine was removed from most of the muscle preparation 155 
leaving one myotome attached to the residual amount of spine at either end.  156 
We conducted isometric studies to determine the twitch and tetanus kinetics of the 157 
isolated muscle according to published protocols 38. We calculated rates of force production 158 
as peak tetanic stress (force per cross-sectional area) divided by 2 x time to half peak tetanus, 159 
and muscle relaxation as peak tetanic stress divided by 2 x time from last stimulus to half 160 
relaxation as measures of the contractile performance of muscle.  161 
 We used the work loop technique to determine the power output (average of each 162 
work loop cycle) of muscles during cyclical length changes 15. Unlike fixed-length isometric 163 
studies and fixed load isotonic studies of muscle performance, the work loop technique 164 
allows measures of muscle power output under length and activation changes that are 165 
generally more indicative of in vivo contractile performance 39. In the absence of in vivo 166 
strain (length change) data for rostral muscle in zebrafish, each muscle preparation was 167 
subjected to a set of four sinusoidal length changes symmetrical around the length found to 168 
generate maximal twitch force. In vivo rostral muscle length changes have been found to 169 
approximate a sinusoidal length change waveform in fish undergoing steady swimming, with 170 
the primary function of such muscle to produce power 40. The muscle was stimulated using 171 
the stimulation amplitude and stimulation frequency found to yield maximal isometric force. 172 
Electrical stimulation and length changes were controlled via a data acquisition board 173 
(KUSB3116, Keithley Instruments, Ohio, USA) and a custom-designed program developed 174 
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via TestPoint software (CEC Testpoint version 7, Measurement Computing, Norton, 175 
Massachusetts, USA). Muscle force was plotted against muscle length for each cycle to 176 
generate a work loop, the area of which equated to the net work produced by the muscle 177 
during the cycle of length change 41. Instantaneous power output was calculated for every 178 
data point in each work loop (2,000 data points per work loop) by multiplying instantaneous 179 
velocity by instantaneous force. These instantaneous power output values were then averaged 180 
to generate an average net power output for each work loop cycle. Every 5 minutes, the 181 
muscle was subjected to a further set of four work loop cycles with length change cycle 182 
frequency (between 3 and 22 Hz), strain, stimulation duration and stimulation phase 183 
parameters being altered in between each set until maximum net work was achieved at each 184 
cycle frequency and maximal power output had been determined.  185 
Every fourth or fifth set of work loop cycles was used as a control run whereby a 186 
fixed set of strain and stimulation parameters were repeated regularly throughout the 187 
experiment to monitor underlying changes in the performance of the muscle over time. On 188 
average the net mean muscle power output per cycle, produced in control runs, decreased by 189 
8.7% over the time course of each experiment. Therefore, the power produced by each 190 
preparation was corrected to the control run that yielded the highest power output (average 191 
power per cycle), assuming that alterations in power generating ability were linear over time 192 
between control runs. 193 
After a further 5 minute rest, fatigue resistance was determined by subjecting the 194 
muscle preparation to a series of tetani, each of 150 ms stimulation duration, at a rate of one 195 
tetanus per second for 25 s. For each muscle, fatigue resistance was calculated as the maximal 196 
force produced in the 25th tetanus as a percentage of the maximal force produced in the 1st 197 
tetanus for the same muscle. Ten minutes after the fatigue run each preparation was 198 
stimulated to produce a further tetanus to determine recovery from the fatigue run. The mean 199 
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recovery of all 30 muscle preparations was 81.1% indicating that reversible fatigue had been 200 
induced. 201 
 At the end of the muscle mechanics experiments, bone and connective tissue were 202 
removed and each muscle preparation was blotted on absorbent paper to remove excess 203 
Ringer’s solution. Wet muscle mass was determined to the nearest 0.1 mg using an electronic 204 
balance (Sartorius, Australia). Mean muscle cross-sectional area was calculated from muscle 205 
length and mass assuming a density of 1060 kg m-3 42. The overall mean cross-sectional area 206 
± s.e. of all 30 muscle preparations was 2.65 ± 0.17 mm2. Maximum isometric muscle stress 207 
(kN m-2) was then calculated for each tetanic response as the maximum tetanic force within 208 
that response divided by mean cross-sectional area. Normalised muscle power output (W kg-209 
1) was calculated as average power output per length change cycle divided by wet muscle 210 
mass. 211 
 212 
Myosin heavy chain concentrations 213 
 We prepared tissue homogenates as described above for measures of citrate synthase 214 
activity. The identification and quantification of slow and fast myosin heavy chain (MHC) 215 
isoforms was performed by capillary electrophoresis in a “Wes” Simple Western System 216 
(ProteinSimple, CA, USA) following the manufacturer's instructions.  The antibodies (all 217 
from Developmental Studies Hybridoma Bank, University of Iowa, USA) we used were: 218 
EB165 to determine fast MHC concentrations; BA-F8 to determine slow MHC 219 
concentrations; 12G10 (α-tubulin) as internal control. We expressed normalised MHC 220 
concentrations by dividing MHC peaks by α-tubulin peaks measured for the same sample on 221 
the same plate. The concentrations of protein extracts was determined using a bicinchoninic 222 
acid assay kit (Sigma-Aldrich, Castle Hill, Australia) following the manufacturer’s 223 
instructions. 224 
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 225 
Statistical analyses 226 
 We analysed data with permutational tests for linear models in the package lmPerm 43 227 
in R 44. Permutational analyses do not make assumptions about underlying data distributions, 228 
but use the data per se to infer significant differences. This approach is preferable to 229 
parametric tests, especially for sample sizes that are small relative to the total population of 230 
all possible samples 45. We analysed all dependent variables (BMI, Ucrit, metabolic rates, 231 
muscle mechanics, MHC concentrations and enzyme activities) with treatment (levels: lean, 232 
obese, obese-lean) as factor. In the analysis comparing power output at different cycle 233 
frequencies, we use treatment as fixed factor, and we used fish id as a random factor within 234 
which we nested the different cycle frequencies to account for repeated measures of the same 235 
muscle preparation at different cycle frequencies. In analyses of Ucrit (in m s-1) we used body 236 
length as covariate, but we show data in units of body lengths s-1. In case of significant 237 
results, we used pair-wise permutational tests for post hoc comparisons, and we used p < 0.05 238 
to indicate significant differences between treatment groups. Sample sizes were based on the 239 
power we achieved using similar techniques on zebrafish in past experiments38,46. 240 
 241 
Results 242 
Obese fish had greater body mass index 243 
 Body mass indices differed significantly between treatments (p < 0.001; Fig. 1), and 244 
lean and obese-lean fish had significantly lower body mass indices than obese fish (both p < 245 
0.001), but there was no difference in body mass index between lean and obese-lean fish (p = 246 
0.63). There was no difference in body mass index between the obese and the obese-lean 247 
groups (p = 0.82) just before the start of diet restriction of the obese-lean group when the 248 
feeding regime was switched from feeding three time per day to once per day. 249 
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 250 
Obesity caused reversible decreases in metabolic scope independently from citrate synthase 251 
activity 252 
 Resting metabolic rates differed significantly between treatments (p = 0.0068; Fig. 253 
2A). Lean and obese-lean fish had similar resting metabolic rates (p = 0.98), and the rates of 254 
both groups were lower than that of the obese fish (p < 0.001 and p = 0.040, respectively for 255 
lean and obese-lean). Maximal metabolic rates also differed between treatments (p = 0.035; 256 
Fig. 1B), and obese fish had significantly lower maximal metabolic rates than lean fish (p = 257 
0.030), but there were no differences between obese-lean and obese (p = 0.72) or lean (p = 258 
0.13) fish. These responses of resting and maximal metabolic rates led to differences in 259 
metabolic scope between treatments (p = 0.0026; Fig. 2C), and lean fish had higher metabolic 260 
scope than obese fish (p = 0.0060), but obese-lean fish did not differ from either of the other 261 
groups (p = 0.13 and p = 0.75, respectively). 262 
 Citrate synthase activity, an indicator of mitochondrial density and metabolic 263 
capacity, did not differ between the treatment groups (p = 0.43; Fig. 2D). 264 
 265 
Obesity caused irreversible changes in locomotor performance and muscle contractile 266 
properties 267 
 There were significant differences in Ucrit between treatments (p = 0.0034; Fig. 3A). 268 
Compared to lean fish, swimming performance was significantly lower in obese (p = 0.044) 269 
and in obese-lean (p = 0.0066) fish, but there was no difference between the latter two groups 270 
(p = 0.27). 271 
 There were significant effects of treatment on muscle isometric stress (force per unit 272 
area; p  = 0.023; Fig. 3F) and muscle work-loop power output (power produced per muscle 273 
mass; p = 0.016; Fig. 3C), and both were lowest in obese-lean fish (lean vs obese-lean: stress 274 
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p = 0.0098, power p < 0.001; obese vs obese-lean: stress p = 0.029, power p = 0.011). There 275 
was a reduction in power and stress in obese fish compared to lean fish, but this was 276 
significant at a one-tailed probability only (stress p = 0.092, power p = 0.086; Fig. 3C and D). 277 
Work loop shapes indicated that most of the difference in normalized power output between 278 
lean and obese-lean fish was due to lean fish generating a higher peak stress in the work loop 279 
and maintaining higher stress during shortening (Fig 3D). Differences in power output 280 
between treatments were apparent only at higher cycle frequencies (interaction between 281 
treatment and cycle frequency p < 0.0001; Fig. 3E). At cycle frequencies of 12 Hz and above, 282 
power output was significantly lower in obese-lean fish compared to lean fish (all p < 0.05), 283 
and obese-lean fish produced less power than obese fish at cycle frequencies of 14 Hz and 284 
above (all p < 0.05; Fig. 3E). Power output of obese fish was variable and we detected no 285 
differences between lean and obese fish (all p > 0.2; Fig. 3E).  286 
 Muscle activation rates were significantly different at a one-tailed probability only (p 287 
= 0.074; Fig. 3G).  Muscle relaxation rates differed significantly between treatments (p = 288 
0.02; Fig. 3H), and relaxation rate was significantly faster in muscle of lean fish compared to 289 
obese-lean fish (p = 0.012); obese fish differed from lean fish with a one-tailed probability (p 290 
= 0.067), but there was no difference in relaxation rate between obese and obese-lean fish. 291 
There were no differences between treatments in muscle fatigue (p = 0.98; Fig. 3B). 292 
 293 
Myosin heavy chains changed irreversibly with obesity  294 
 Obesity treatment had a significant effect on (normalised) slow myosin heavy chain 295 
concentrations (p < 0.001; Fig. 4A).  Lean fish had significantly greater concentrations than 296 
obese (p = 0.012), and obese-lean (p = 0.0062) fish, but there was no difference between the 297 
latter two groups (p = 0.75). Similarly, concentrations of fast myosin heavy chains changed 298 
with treatment (p = 0.044; Fig. 4B), and compared to lean fish obese-lean fish had 299 
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significantly lower concentrations of fast myosin heavy chains (p = 0.025), but the decrease 300 
in obese fish was significant at a 1-tailed probability only (p = 0.078). Muscle composition 301 
changed with treatment (treatment effect p = 0.0096, Fig. 4C), and the ratio between 302 
slow:fast myosin heavy chains was significantly lower in obese (p = 0.029) and obese-lean 303 
fish (p = 0.010) than in lean fish, but obese fish were not different from obese-lean fish (p = 304 
0.96). 305 
 306 
Discussion 307 
 We have shown that declines in metabolic scope in obese individuals are reversed by 308 
weight loss, but declines in muscle contractile function and locomotion are not. These results 309 
indicate that weight gain and loss influence metabolic responses directly, but that the effect 310 
of obesity on muscle phenotypes is not mediated directly by changes in body mass (BMI). 311 
The implication of our finding is that weight loss alone may be an insufficient treatment for 312 
obese pathologies.  313 
 Zebrafish are well established now in the literature as a model for obesity6,7,47, 314 
metabolic disease 48 and exercise 49-51. Overfeeding in zebrafish led to rapid weight gain and 315 
a significant increase in body mass index (1.1-1.3 fold) compared to control fish after 1-2 316 
weeks 7. Similar to the effects of weight gain and obesity in humans, the increase in body 317 
mass resulted in pathophysiological conditions such as hypertriglyceridemia and 318 
hepatosteatosis 7,52. Hence, that level of weight gain (>1.1-1.3 increase from lean body mass 319 
index) may be defined functionally as obese 53,54. As in mice and humans, disruption of the 320 
adipostat system caused obesity in zebrafish6, and leptin receptor deficiency in zebrafish 321 
disrupted glucose homeostasis, but it did not cause hyperphagia 55. Exercise training in 322 
zebrafish increased muscle mass51, myogenin levels, and shifted skeletal muscle to a slower 323 
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and more aerobic fibre type 56.These responses are broadly similar to those of other 324 
vertebrates 2,57, which makes zebrafish a good exercise model for biomedical research 50.  325 
 The (patho)physiological similarities between zebrafish and humans, combined with 326 
the lower cost and increased tractability of conducting experimental and screening studies on 327 
zebrafish compared to rodents or humans47,48,58,59 mean that zebrafish have increasing 328 
translational impact 59,60 Zebrafish are particularly suitable for studies on muscle function and 329 
exercise because the methodologies to determine muscle and locomotor performance are well 330 
estabished in fish 61-63. We recently optimised isometric techniques to measure muscle 331 
performance in zebrafish 38, which we extended here to include the work-loo technique. 332 
These techniques are particularly powerful in a zebrafish model, because here it utilises most 333 
of the locomotory muscle assembly to provide a functional measure of muscle performance, 334 
which is more realistic than approaches that use only single fibres from biopsies as is the case 335 
for human studies. Hence, for our study, as well as for many others47, zebrafish were a 336 
superior model than humans, in terms of quality of data, sample sizes, and practicality in 337 
terms of manipulating weight gain and weight loss under controlled experimental conditions. 338 
 Chronic feeding on high-energy diets and a sedentary lifestyle lead to an imbalance in 339 
glucose metabolism and insulin signaling, which can lead to obesity and metabolic diseases4. 340 
A mechanism by which these effects can be mediated is the action of the SIRT1, which in 341 
association with AMPK activity regulates fatty acid oxidation and energy homeostasis 10. 342 
SIRT1 levels are increased by caloric restriction and are decreased by overfeeding 4. 343 
Adiponectin, the levels of which decrease with obesity but are restored by weight loss 26, 344 
stimulates the SIRT1/AMKP axis 64. Together, the actions of these molecules provide a 345 
mechanistic link between excessive feeding and obesity on the one hand, and metabolic 346 
dysfunction on the other 65, and may explain why metabolic dysfunction is reversible by 347 
decreased feeding and weight loss. Our finding that obesity-induced decreases in metabolic 348 
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scope are reversible by reduced feeding and weight loss are similar to responses from 349 
mammals. The decrease in (mass specific) maximal metabolic rates was expected from 350 
obesity-induced metabolic dysfunction, and from the increase in adiposity in obese 351 
individuals. However, the decreases in maximal metabolic rates were not associated with 352 
decreased citrate synthase activities, which indicates that mitochondrial densities in muscle 353 
were not altered by obesity 34. The observed increases in resting metabolic rate may be due to 354 
increased inflammation and its attendant increase in resting metabolic demand 66, but this 355 
suggestion should be verified in a zebrafish model.  356 
 Surprisingly, the obesity-induced decreases in muscle contractile function and 357 
locomotor capacity were not reversible by weight loss in our zebrafish. High fat diet caused a 358 
shift in myosin heavy chains towards faster isoforms in rhesus monkeys, and that shift was 359 
partly reversed with resveratrol, a drug that stimulates the SIRT1 pathway and promotes 360 
mitochondrial proliferation 67. Decreases in adiponectin and its receptor AdipoR1 can also 361 
decrease oxidative type I myofibres 64. However, if adiponectin and SIRT1 levels are restored 362 
by weight loss, as suggested in the literature, some other mechanisms must regulate muscle 363 
function and myosin heavy chain expression in our zebrafish. Our data indicate that muscle 364 
of obese and obese-lean fish had low myofibrillar density (low MHC concentrations), and 365 
this decrease can explain the decreases in muscle stress and power output. The increasing 366 
difference in power output between treatments with increasing cycle frequency confirm this 367 
suggestion, because the effect of low myofibrillar density would be particularly pronounced 368 
as muscle works harder and at higher cycle frequencies. The cycle frequencies of the work 369 
loop assays are proportional to tail beat frequencies in swimming fish 15, and tail beat 370 
frequencies are proportional to swimming speed 68. Hence, the reduction in myosin heavy 371 
chain concentrations and power output at high cycle frequencies can explain the decreases in 372 
Ucrit we observed in obese and obese-lean individuals. The reduction in MHC concentration, 373 
 16 
and the shift from slow to fast MHC could be due to impaired signalling pathways that 374 
mediate expression of muscle proteins. For example, expression of calcium handling and 375 
contractile proteins in skeletal muscle is regulated by the interaction between myocyte 376 
enhancer factor 2 (MEF2) and histone deacetylases (HDAC) 2. Obesity can lead to a 377 
disruption of the transcriptional regulation of muscle phenotypes, thereby leading to 378 
decreased muscle mass and strength 69, which provides a explanatory model for the changes 379 
in MHC levels we observed that can be tested in zebrafish and other obesity models. 380 
 Tail beat frequency, and hence swimming performance, is sensitive to calcium release 381 
and resequestration into the sarcoplasmic reticulum 68. Obesity can  alter calcium (Ca2+) 382 
concentrations 70 and reduce sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) activity 71, 383 
which provides a second avenue by which obesity can constrain locomotion at higher speeds 384 
(i.e. cycle frequencies - tail beat frequencies).  Muscle contraction is mediated by the release 385 
of Ca2+ from the sarcoplasmic reticulum following neural stimulation of dihydropyridine 386 
receptors and their interaction with ryanodine receptors 72. Free Ca2+ mediates muscle 387 
contraction by binding to troponin in a concentration-dependent manner. Muscle relaxation is 388 
mediated by re-sequestration of Ca2+ into the sarcoplasmic reticulum via SERCA 57. 389 
Disruption of Ca2+ dynamics will attenuate muscle contractile properties 57 and decrease 390 
locomotor performance 68. The reduction in relaxation rate indicates that obesity reduced 391 
SERCA activity and thereby slowed re-sequestration of Ca2+ into the sarcoplasmic reticulum 392 
and muscle relaxation. Similarly, the (one-tailed) decrease in activation rate suggests that the 393 
rate of Ca2+ release from the sarcoplasmic reticulum is reduced following stimulation. 394 
Depletion of Ca2+ stores in the sarcoplasmic reticulum can also reduce stress and power 395 
output 57. However, store depletion is unlikely, because fatigue resistance, which is at least 396 
partly determined by store depletion 73, was not affected by obesity.  397 
 Zebrafish are an excellent model to test obesity-induced changes on skeletal muscle, 398 
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because it is easier to isolate the effects of obesity on muscle per se. In terrestrial animals, 399 
including humans, obesity increases the in vivo strength of postural ‘antigravity’ muscles as a 400 
result of a training effect from the increased load during standing and locomotion 74, which 401 
can obscure the effects of obesity on locomotor muscle. Our data are important because we 402 
show that the effects of obesity persist beyond weight loss. Weight loss is an essential 403 
intervention for obesity, but our data indicate that it is not sufficient to restore healthy, pre-404 
obese phenotypes. The average lifespan of zebrafish is around 5% that of humans 75. Hence, 405 
the period of diet restriction (4-5 weeks) in our experiments represents a reasonably long 406 
time in human terms.  An important outstanding question now is whether the observed 407 
changes, such as myosin heavy chain concentrations and composition, can revert back to pre-408 
obesity levels. Even though there can be a training effect of postural muscle as a result of 409 
supporting larger mass 74, obesity leads to reductions in motor control 76 and it is often 410 
associated with sedentary lifestyles 77 so that the mass-induced training effect would be 411 
minimised 78. Exercise intervention could be effective in restoring muscle function as well as 412 
weight loss 79. An interesting future direction will be to determine the link between 413 
transcriptional regulation of muscle phenotypes and changes in the contractile apparatus of 414 
skeletal muscle during obesity and following weight loss in both the zebrafish model and in 415 
humans directly. Understanding the role of exercise in influencing these pathways during or 416 
following weight loss could lead to developing effective programs to reverse the negative 417 
effects of obesity on muscle function and locomotor capacity.  418 
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Figure captions 652 
Figure 1 Body mass indices of the treatment groups. Lean (L) and obese-lean (OL; obese 653 
fish that underwent weight loss) fish had similar body mass indices (BMI), which were 654 
significantly lower that those of obese (O) fish. The BMI of the obese group was not different 655 
from that of the obese-lean group just before diet restriction when the feeding regime was 656 
switched from three time to once per day (OL/O). Means ± s.e. are shown, and letters above 657 
bars indicate significant differences. 658 
 659 
Figure 2 Metabolic responses of zebrafish to obesity and weight loss. Obese (O) fish had 660 
significantly greater resting metabolic rates than lean (L) or obese-lean (OL) fish (A), but 661 
maximal metabolic rates of obese fish were lower than in lean fish (B). Maximal metabolic 662 
rates of obese-lean fish were not different from lean or obese fish. Metabolic scope was 663 
reduced in obese fish (C), but at least partly restored after weight loss in obese-lean fish. 664 
Citrate synthase activity, an indicator of mitochondrial density, did not differ significantly 665 
between treatment groups (D). Means ± s.e. are shown, and letters above bars indicate 666 
significant differences. n = 12 lean, 14 obese, and 9 lean-obese fish for all metabolic rate 667 
measures, and n = 8 fish per treatment group for citrate synthase activity. 668 
 669 
Figure 3 Muscle mechanics and locomotor performance in response to obesity and weight 670 
loss. Sustained swimming performance (Ucrit; A), isometric stress (force per unit area, F), 671 
dynamic muscle power output determined by the work-loop technique (C), and muscle 672 
relaxation rates (H ) were lower in obese (O) individuals compared to lean (L) fish, and 673 
 28 
stayed at a reduced level even after weight loss (obese-lean, OL). An example of a typical 674 
work loop shape (D) demonstrates that muscle of lean fish (broken line) produced greater 675 
stress and maintained stress to a greater extent during shortening (decreasing strain) 676 
compared to obese-lean fish (solid line). Differences in muscle power output between 677 
treatments were apparent at high cycle frequencies (E; significant differences indicated by an 678 
asterisk). Activation rate (G) showed similar reductions in obese and obese-lean individuals, 679 
but the differences were significant at a one-tailed probability only. There was no effect of 680 
treatment on muscle fatigue (B). Means ± s.e. are shown, and letters above bars indicate 681 
significant differences. An hash next to a letter (e.g. a#) indicates differences with a one-682 
tailed probability. For Ucrit, n = 12 lean, 14 obese, and 9 obese-lean fish, and n = 10 fish per 683 
treatment group for measures of muscle mechanics.  684 
 685 
Figure 4 Myosin heavy chain concentrations in response to obesity and weight loss. Slow 686 
(A) and fast (B) myosin heavy chain concentrations (MHC; normalised to -tubulin) were 687 
significantly lower in obese (O) and obese-lean (OL) individuals compared to lean controls 688 
(L). The slow:fast MHC ratio was lower in obese and obese-lean individuals, indicating a 689 
shift in muscle composition (C). Means ± s.e. are shown, and letters above bars indicate 690 
significant differences. An hash next to a letter (e.g. a#) indicates differences with a one-691 
tailed probability. N = 6 individuals for each treatment group.  692 
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